Inactive Instrument

News Novozymes A/S Other OTC

Equities

Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024	03/05
Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration	03/05	GL
Trading statement Q1 2024	03/05	GL
Novonesis Provides Sales Guidance for the Year 2024	03/05	CI
Final dividend	01/05	FA
Novonesis A/S : Resolutions from the annual shareholders' meeting 2024	30/04	PU
Resolutions from the annual shareholders’ meeting 2024	30/04	GL
Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	30/04	CI
Novonesis A/S : Invitation to the annual shareholders' meeting	08/04	PU
Invitation to the annual shareholders’ meeting	08/04	GL
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	08/04	CI
Share-based legacy RSU program granted	08/04	GL
China to speed up 'new productive forces', vice president says	26/03	RE
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders	21/03	DJ
Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024	21/03
Novonensis expects 2024 adjusted EBITDA margin of 35%	21/03	RE
2024 outlook and pro forma financials	21/03	GL
2024 outlook and pro forma financials	21/03	AQ
Novonesis Provides Earnings Guidance for the Year 2024	21/03	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	18/03	MT

No results for this search

NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments

February 08, 2024 at 07:48 pm IST